Skip to main content

One Lambda HLA Software Cleared by US, Canadian Regulators

NEW YORK (GenomeWeb News) – Regulators in the US and Canada have cleared One Lambda's companion software to molecular typing and antibody screening products, the Thermo Fisher Scientific business said late Wednesday.

The US Food and Drug Administration cleared the HLA Fusion Software version 3.0, while Canada's Ministry of Health has also granted the software a Health Canada License.

One Lamba's software is used to help personnel experienced in HLA analysis by suggesting typing and antibody screening results, the company said, adding that HLA Fusion Software version 3.0 is intended as a laboratory aid, not for definitive results.

Thermo Fisher acquired One Lambda, which specializes in transplant diagnostics, in September for $925 million.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.